Product Description

Plaintiffs alleged in publicly filed U.S. asbestos personal-injury and wrongful-death litigation that Johnson & Johnson’s iconic Johnson’s Baby Powder and the related Shower to Shower body powder were allegedly contaminated with tremolite, anthophyllite, and chrysotile asbestos through the mineral talc supply chain. The contamination theory identifies J&J’s principal talc sources over the product’s history — Vermont mines operated by J&J subsidiary Windsor Minerals, historical Italian talc sources, and later Chinese sources — as geologically co-located with asbestiform amphibole and serpentine deposits.

Publicly filed litigation has alleged that J&J had knowledge of amphibole-fiber findings in its raw talc for decades and allegedly continued to market the product for infant care, perineal use, and daily body-dusting without adequate warning. In 2020, J&J discontinued North American sales of talc-based Johnson’s Baby Powder and reformulated to cornstarch; worldwide talc-based sales were discontinued in 2023.

Workers Exposed and Household Consumers

  • Women using Johnson’s Baby Powder and Shower to Shower daily — perineal application, body dusting, and after-shower use — the primary consumer-inhalation population
  • Parents dusting infants with Johnson’s Baby Powder during diaper changes across decades of American infant care
  • Salon workers and cosmetologists applying J&J talc to clients
  • Household contact exposure — everyone in the room during application
  • Retail workers stocking and demonstrating J&J talc products
  • Johnson & Johnson production and packaging employees at talc-processing facilities
  • Windsor Minerals VT talc-mine workers extracting the raw mineral

If You Used Johnson’s Baby Powder or Shower to Shower

If you or a family member used Johnson’s Baby Powder or Shower to Shower over years or decades and were later diagnosed with mesothelioma, ovarian cancer, or another asbestos-related disease, publicly filed cosmetic-talc litigation has established J&J’s talc products as central defendants in this litigation.

Free, confidential case evaluation: Speak with O’Brien Law Firm — (314) 936-2956